More than three-quarters of children with intractable migraine who try the therapy have obtained relief and come back every three months for another round. We share learnings from our experience to date.
Outcomes from Cleveland Clinic’s use of chemodenervation therapy for movement disorders and migraine underscore why this modality is well worth a try before weighing more invasive therapies.
How botulinum toxin plays an important role in the conservative management of TMJ and many other noncosmetic head and neck conditions.
Cleveland Clinic’s Head & Neck Institute has found botulinum toxin (BTX) to be effective for pediatric facial nerve dysfunction and two other fairly common conditions in children.